Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus

Sponsor
Government Dental College and Research Institute, Bangalore (Other)
Overall Status
Completed
CT.gov ID
NCT02386020
Collaborator
(none)
60
2
6

Study Details

Study Description

Brief Summary

The present study is designed to investigate the effectiveness of AV gel local drug delivery as an adjunct to scaling and root planing (SRP) in the treatment of subjects with chronic periodontitis (CP) and type 2 diabetes mellitus (DM).

Condition or Disease Intervention/Treatment Phase
  • Drug: aloe vera
  • Drug: placebo gel
Phase 2/Phase 3

Detailed Description

BACKGROUND: Advances in the field of alternative medicine have promoted widespread use of herbal agents, like Aloe vera (AV), for both medical and dental therapy. AV has anti-inflammatory, antioxidant, antimicrobial, hypoglycaemic, healing promoting and immune boosting properties. The present study is designed to investigate the effectiveness of AV gel local drug delivery as an adjunct to scaling and root planing (SRP) in the treatment of subjects with chronic periodontitis (CP) and type 2 diabetes mellitus (DM).

MATERIAL AND METHODS: A total of 60 subjects with probing depth (PD) ≥5mm and clinical attachment level (CAL) ≥3mm were randomly divided into two groups. Group 1 was treated with SRP + placebo gel local drug delivery (LDD) and Group 2 with SRP + AV gel LDD. Clinical parameters including full mouth plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD) and clinical attachment level (CAL) were recorded first at baseline and then at intervals of 3 months and 6 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Clinical Efficacy of Locally Delivered Aloe Vera Gel as an Adjunct to Non-surgical Periodontal Therapy in Chronic Periodontitis Subjects With Type 2 Diabetes Mellitus: a Randomized Controlled Clinical Trial
Study Start Date :
Jun 1, 2014
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo

After SRP, placebo gel was delivered subgingivally into periodontal pockets.

Drug: placebo gel
After SRP, placebo gel was delivered subgingivally into periodontal pockets.

Active Comparator: Aloe vera

After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.

Drug: aloe vera
After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.

Outcome Measures

Primary Outcome Measures

  1. Change in Clinical attachment level [baseline to 6 months]

Secondary Outcome Measures

  1. Change in Plaque index [baseline to 6 months]

  2. Change in modified sulcus bleeding index [baseline to 6 months]

  3. Change in Probing depth [baseline to 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Well-controlled type 2 DM

  • Chronic periodontitis with moderate to deep pockets [probing depth (PD) ≥5mm and clinical attachment loss (CAL) ≥3mm]

  • No history of antibiotic or periodontal therapy in the preceding 6 months.

Exclusion Criteria:
  • Any known disease/condition or on any medication that can affect the periodontal status

  • Known or suspected allergy to herbal medications

  • Systemic antimicrobial therapy

  • Aggressive periodontitis

  • Smokers

  • Alcoholics

  • Immunocompromised patients

  • Pregnant or lactating females

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Government Dental College and Research Institute, Bangalore

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. A R Pradeep, Professor & Head, Department of Periodontology, Government Dental College and Research Institute, Bangalore
ClinicalTrials.gov Identifier:
NCT02386020
Other Study ID Numbers:
  • GDCRI/ACM/PG/PhD/10E/2013-14
First Posted:
Mar 11, 2015
Last Update Posted:
Mar 11, 2015
Last Verified:
Feb 1, 2015

Study Results

No Results Posted as of Mar 11, 2015